Biocon stages strong quarterly operational performance
Biocon has registered a consolidated net profit of Rs 223 crore for the quarter ended March. Zee Business analysts had pegged the biopharmaceutical companys March-quarter net profit at Rs 180 crore. Its quarterly stood at 23.4 per cent, better than the analysts estimate of 21.6 per cent. Q4FY24 YOY CONSOL PAT at Rs.223cr vs 415cr, -46% (Est 180cr) Other income at Rs.49cr vs 155cr
Biocon has registered a consolidated net profit of Rs 223 crore for the quarter ended March. Zee Business analysts had pegged the biopharmaceutical company's March-quarter net profit at Rs 180 crore.
Its quarterly stood at 23.4 per cent, better than the analysts' estimate of 21.6 per cent.
Q4FY24 YOY CONSOL
PAT at Rs.223cr vs 415cr, -46% (Est 180cr)
Other income at Rs.49cr vs 155cr
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.